Impact of COVID-19 on pacemaker implant

Ana C Gonzales-Luna1,2, Javier O Torres-Valencia1, Javier E Alarcón-Santos1,3

  • 1Department of Cardiology Edgardo Rebagliati Martins National Hospital Lima Peru.

Journal of Arrhythmia
|August 25, 2020
PubMed

Insights

The COVID-19 pandemic significantly reduced pacemaker implantations by 73%. This decrease in new pacemaker surgeries occurred across all patient etiologies, highlighting the pandemic's impact on cardiovascular procedures.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic led to mandatory social isolation measures.
  • These measures resulted in decreased activity within cardiology units.
  • This study examines the impact on pacemaker implantation rates.

Purpose of the Study:

  • To determine the change in pacemaker implantation volume during the COVID-19 pandemic.
  • To assess how pacemaker implant numbers changed based on etiology during the pandemic.

Main Methods:

  • A descriptive, cross-sectional study was conducted using a Peruvian hospital database.
  • The study period was divided into 'Before COVID', 'Previous to Social Isolation', and 'Social Isolation' phases.
  • Pacemaker implantations were compared across these time periods.

Main Results:

  • A significant 73% reduction in pacemaker implantations was observed during the COVID-19 pandemic.
  • A 78% reduction was noted in patients with complete or high-grade atrioventricular block.
  • Reductions in de-novo pacemaker implants occurred regardless of the underlying etiology.

Conclusions:

  • The study found a substantial 73% decrease in de-novo pacemaker implantations during the COVID-19 pandemic.
  • This reduction in new pacemaker surgeries was independent of the patient's specific etiology.
  • The findings underscore the pandemic's significant impact on elective cardiovascular interventions.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
182
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
239
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
149
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
168
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
479
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
126